We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Amryt Pharma Plc | LSE:AMYT | London | Ordinary Share | GB00BKLTQ412 | ORD 6P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 143.00 | 151.00 | 170.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMAMYT
RNS Number : 7304O
Amryt Pharma PLC
03 October 2019
TR-1: Standard form for notification of major holdings
Hot Features
Premium
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying
issuer of existing shares to which voting Amryt Pharma PLC
rights are at- tachedii:
----------------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
------
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights
------
An acquisition or disposal of financial instruments
------
An event changing the breakdown of voting rights
------
Other (please specify)iii: Intra group transfer X
------
3. Details of person subject to the notification obligationiv
Name Athyrium Funds GP Holdings LLC
----------------------------------------------------------
City and country of registered office Delaware, USA
(if applicable)
----------------------------------------------------------
4. Full name of shareholder(s) (if different from 3.)v
Athyrium Opportunities II Acquisition
Name LP, Athyrium Opportunities II Acquisition
2 LP, Athyrium Opportunities III Acquisition
LP, and
Athyrium Opportunities III Acquisition
2 LP
----------------------------------------------------------
City and country of registered office Delaware, USA
(if applicable)
----------------------------------------------------------
5. Date on which the threshold was crossed 24/9/2019
or reachedvi:
----------------------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 26/9/2019
----------------------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting rights % of voting rights Total number
at- tached to through financial Total of both of voting rights
shares (to- tal instru- ments in % (8.A + 8.B) of is- suervii
of 8. A) (total of 8.B 1
+ 8.B 2)
-------------------- ----------------------- ----------------------- --------------------
Resulting situation
on the date on
which threshold
was
crossed or reached 27.2% 0 27.2% 157,718,438
-------------------- ----------------------- ----------------------- --------------------
1
Position of previous
notification (if
applicable) 27.2% 0 27.2%
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of Number of voting rightsix % of voting rights
shares
ISIN code (if
possible)
-------------------------------------------------------- --------------------------------------------------------
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
------------------------- ----------------------------- ----------------------------- -------------------------
GB00BKLTQ412 0 42,883,097 0 27.2%
------------------------- ----------------------------- ----------------------------- -------------------------
SUBTOTAL 8. A 42,883,097 27.2%
-------------------------------------------------------- --------------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Number of voting
Type of Expiration Exercise/ Conversion rights that may be % of voting rights
financial datex Periodxi acquired if the instrument
in- strument is exercised/converted.
------------ -------------------------------------- --------------------------------- -------------------------
SUBTOTAL 8. B 1
-------------------------------------- --------------------------------- -------------------------
B 2: Financial Instruments with similar economic effect according to Art.
13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Conversion Physical or Number of
financial datex Pe- cash voting rights % of voting rights
instrument riod xi settlementxii
----------------- ------------------------- ----------------------- --------------------- -------------------------
SUBTOTAL 8.B.2
----------------------- --------------------- -------------------------
9. Information in relation to the person subject to the notification obligation
(please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by
any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the (underlying)
issuerxiii
------
Full chain of controlled undertakings through which the voting rights
and/or the X
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entityxiv (please add additional
rows as necessary)
------
% of voting rights % of voting rights Total of both if
if it equals or is through financial it equals or is higher
Namexv higher than the notifiable in- struments if than the notifiable
threshold it equals threshold
or is higher than
the notifiable threshold
----------------------------- ----------------------------- ------------------------------
Jeffrey Ferrell 27.2% 0 27.2%
----------------------------- ----------------------------- ------------------------------
Athyrium Funds GP
Holdings LLC 27.2% 0 27.2%
----------------------------- ----------------------------- ------------------------------
Athyrium GP Holdings
LLC 15.8% 0 15.8%
----------------------------- ----------------------------- ------------------------------
Athyrium Opportunities
Associates II LP 15.8% 0 15.8%
----------------------------- ----------------------------- ------------------------------
Athyrium Opportunities
II Acquisition LP 0 0 0
----------------------------- ----------------------------- ------------------------------
Jeffrey Ferrell 27.2% 0 27.2%
----------------------------- ----------------------------- ------------------------------
Athyrium Funds GP
Holdings LLC 27.2% 0 27.2%
----------------------------- ----------------------------- ------------------------------
Athyrium GP Holdings
LLC 15.8% 0 15.8%
----------------------------- ----------------------------- ------------------------------
Athyrium Opportunities
Associates II LP 15.8% 0 15.8%
----------------------------- ----------------------------- ------------------------------
Athyrium Opportunities
II Acquisition 2
LP 15.8% 0 15.8%
----------------------------- ----------------------------- ------------------------------
Jeffrey Ferrell 27.2% 0 27.2%
----------------------------- ----------------------------- ------------------------------
Athyrium Funds GP
Holdings LLC 27.2% 0 27.2%
----------------------------- ----------------------------- ------------------------------
Athyrium Opportunities
Associates III GP
LLC 11.4% 0 11.4%
----------------------------- ----------------------------- ------------------------------
Athyrium Opportunities
Associates III LP 11.4% 0 11.4%
----------------------------- ----------------------------- ------------------------------
Athyrium Opportunities
III Acquisition LP 0 0 0
----------------------------- ----------------------------- ------------------------------
Jeffrey Ferrell 27.2% 0 27.2%
-------------- --- ----------
Athyrium Funds GP
Holdings LLC 27.2% 0 27.2%
-------------- --- ----------
Athyrium Opportunities
Associates III GP
LLC 11.4% 0 11.4%
-------------- --- ----------
Athyrium Opportunities
Associates III LP 11.4% 0 11.4%
-------------- --- ----------
Athyrium Opportunities
III Acquisition 2
LP 11.4% 0 11.4%
-------------- --- ----------
10. In case of proxy voting, please identify:
Name of the proxy holder
---------------
The number and % of voting rights held
---------------
The date until which the voting rights
will be held
---------------
11. Additional informationxvi
All shares held by Athyrium Opportunities II Acquisition LP were transferred
to Athyrium Opportunities II Acquisition 2 LP such that Athyrium Opportunities
II Acquisition 2 LP holds 15.8%
All shares held by Athyrium Opportunities III Acquisition LP were transferred
to Athyrium Opportunities III Acquisition 2 LP such that Athyrium Opportunities
III Acquisition 2 LP holds 11.4%
Place of completion New York, NY USA
Date of completion 26/9/2019
-----------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
HOLEXLFBKBFXFBF
(END) Dow Jones Newswires
October 03, 2019 11:38 ET (15:38 GMT)
1 Year Amryt Pharma Chart |
1 Month Amryt Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
